DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,922,263 | +3.7% | 39,993 | +0.3% | 2.86% | +8.6% |
| Q2 2023 | $9,566,640 | -5.1% | 39,861 | -0.4% | 2.63% | -11.3% |
| Q1 2023 | $10,085,633 | -7.9% | 40,016 | -3.0% | 2.96% | -14.1% |
| Q4 2022 | $10,944,859 | +2.7% | 41,236 | -0.1% | 3.45% | -2.8% |
| Q3 2022 | $10,660,000 | +2.1% | 41,271 | +0.2% | 3.55% | +9.0% |
| Q2 2022 | $10,438,000 | -15.0% | 41,171 | -1.6% | 3.26% | +3.8% |
| Q1 2022 | $12,278,000 | -12.1% | 41,856 | -1.4% | 3.14% | -4.3% |
| Q4 2021 | $13,966,000 | +8.2% | 42,450 | +0.2% | 3.28% | -3.0% |
| Q3 2021 | $12,903,000 | +13.6% | 42,385 | +0.1% | 3.38% | +13.3% |
| Q2 2021 | $11,361,000 | +16.8% | 42,335 | -2.1% | 2.99% | +7.9% |
| Q1 2021 | $9,731,000 | -1.0% | 43,233 | -2.3% | 2.77% | -0.9% |
| Q4 2020 | $9,831,000 | +2.6% | 44,257 | -0.6% | 2.79% | -8.7% |
| Q3 2020 | $9,585,000 | +22.4% | 44,513 | +0.5% | 3.06% | +9.1% |
| Q2 2020 | $7,829,000 | +27.8% | 44,273 | 0.0% | 2.81% | -0.0% |
| Q1 2020 | $6,128,000 | -10.2% | 44,273 | -0.5% | 2.81% | +9.2% |
| Q4 2019 | $6,827,000 | -5.3% | 44,483 | -10.9% | 2.57% | -8.3% |
| Q3 2019 | $7,211,000 | +2.8% | 49,933 | +1.7% | 2.80% | +1.4% |
| Q2 2019 | $7,017,000 | +4.2% | 49,098 | -3.8% | 2.77% | +0.8% |
| Q1 2019 | $6,735,000 | +23.0% | 51,016 | -3.9% | 2.74% | +7.1% |
| Q4 2018 | $5,475,000 | -6.7% | 53,091 | -1.7% | 2.56% | +12.3% |
| Q3 2018 | $5,868,000 | +9.3% | 54,007 | -0.7% | 2.28% | +2.7% |
| Q2 2018 | $5,367,000 | -1.5% | 54,388 | -2.2% | 2.22% | -2.9% |
| Q1 2018 | $5,447,000 | +5.0% | 55,628 | -0.4% | 2.29% | +6.8% |
| Q4 2017 | $5,186,000 | +4.9% | 55,873 | -3.1% | 2.14% | -1.2% |
| Q3 2017 | $4,945,000 | +1.1% | 57,643 | -0.5% | 2.17% | -1.5% |
| Q2 2017 | $4,890,000 | -1.7% | 57,943 | -0.3% | 2.20% | -0.9% |
| Q1 2017 | $4,973,000 | +9.9% | 58,143 | 0.0% | 2.22% | +8.7% |
| Q4 2016 | $4,526,000 | -18.9% | 58,143 | -18.3% | 2.04% | -12.5% |
| Q3 2016 | $5,580,000 | -26.4% | 71,181 | -5.2% | 2.33% | -26.1% |
| Q2 2016 | $7,583,000 | +6.8% | 75,081 | +0.3% | 3.16% | +4.3% |
| Q1 2016 | $7,099,000 | +0.9% | 74,831 | -1.3% | 3.03% | +0.9% |
| Q4 2015 | $7,038,000 | +8.7% | 75,781 | -0.2% | 3.00% | +3.4% |
| Q3 2015 | $6,472,000 | -0.6% | 75,956 | -0.1% | 2.90% | +6.6% |
| Q2 2015 | $6,509,000 | +0.2% | 76,056 | -0.6% | 2.72% | -2.4% |
| Q1 2015 | $6,496,000 | -7.2% | 76,516 | -6.3% | 2.79% | -8.2% |
| Q4 2014 | $7,001,000 | +6.3% | 81,681 | -5.8% | 3.04% | +6.1% |
| Q3 2014 | $6,588,000 | -3.0% | 86,706 | +0.5% | 2.86% | -0.9% |
| Q2 2014 | $6,791,000 | +4.1% | 86,256 | -0.8% | 2.89% | -3.3% |
| Q1 2014 | $6,521,000 | -3.1% | 86,956 | -0.3% | 2.99% | -4.6% |
| Q4 2013 | $6,732,000 | +9.8% | 87,206 | -1.4% | 3.13% | +0.2% |
| Q3 2013 | $6,129,000 | +6.8% | 88,416 | -2.5% | 3.13% | +27.4% |
| Q2 2013 | $5,739,000 | – | 90,666 | – | 2.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |